metformin has been researched along with rosiglitazone-metformin combination in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (45.16) | 29.6817 |
| 2010's | 16 (51.61) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Del Prato, S; Volpe, L | 1 |
| Bailey, CJ; Day, C | 1 |
| Cobitz, A; Garber, A; Huang, C; Rood, J; Rosenstock, J | 1 |
| Biswas, N; Chou, H; Cobitz, A; Garber, A; Rood, J; Rosenstock, J | 1 |
| Kanna, B; Pokharna, H | 1 |
| Bailey, CJ; Chen, H; Donaldson, J; Home, PD; Stewart, MW | 1 |
| Garber, A | 1 |
| Balabolkin, MI; Klebanova, EM; Kreminskaia, VM; Kuzin, AG; Mamaeva, GG; Tel'nova, ME | 1 |
| Cheng, AY; Josse, RG | 1 |
| Onal, A | 1 |
| Acusta, AP; Ambery, PD; Bilezikian, JP; Borges, JL; Cobitz, AR; Fitzpatrick, LA; Grosse, M; Jones-Leone, AR; Nino, AJ | 1 |
| Hanley, AJ; Harris, SB; Retnakaran, R; Ye, C; Zinman, B | 1 |
| Doubova, SV; Flores-Hernández, S; Mino-León, D; Reyes-Morales, H | 1 |
| Dyer, C | 1 |
| Kamal, MF; Khamis, EF; Korany, MA; Mahgoub, H; Youssef, RM | 1 |
| Coggan, AR; Gropler, RJ; Herrero, P; Lyons, MR; McGill, JB; Peterson, LR; Recklein, C; Saeed, IM; Schechtman, KB | 1 |
| Bi, Y; Dai, YY; Feng, WH; Hu, J; Hu, Y; Li, P; Liu, YQ; Shao, LL; Shen, SM; Tong, GY; Wang, WM; Xiang, SK; Yang, DH; Yuan, XW; Zhu, DL | 1 |
| Cai, XL; Chen, YL; Gu, W; Hong, TP; Ji, LN; Li, CJ; Qiu, MC; Shan, ZY; Tian, HM; Xue, YM; Yang, HZ; Yang, JK; Zhao, JJ | 1 |
| Freeman, R; Mogul, H; Nguyen, K | 1 |
| El Ghormli, L; Hirst, K; Ievers-Landis, CE; Linder, B; Marcus, MD; van Buren, DJ; Walders-Abramson, N; Wilfley, DE; Zeitler, P | 1 |
| Arslanian, S; Bacha, F; Caprio, S; El Ghormli, L; Goland, R; Haymond, MW; Levitsky, L; Nadeau, KJ; White, NH; Willi, SM | 1 |
| Hsieh, CY; Li, CY; Lu, CH; Ou, HT; Yang, CY | 1 |
| Copeland, KC; Dhaliwal, R; El Ghormli, L; Geffner, ME; Higgins, J; Levitsky, LL; Nadeau, KJ; Shepherd, JA; Weinstock, RS; White, NH | 1 |
| Chandran, A; Drews, K; El Ghormli, L; Sylvetsky, AC; Talegawkar, SA; Welsh, JA | 1 |
2 review(s) available for metformin and rosiglitazone-metformin combination
| Article | Year |
|---|---|
Rosiglitazone plus metformin: combination therapy for Type 2 diabetes.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazoles; Thiazolidinediones | 2004 |
Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.
Topics: Contraindications; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Thiazoles; Treatment Outcome | 2004 |
14 trial(s) available for metformin and rosiglitazone-metformin combination
| Article | Year |
|---|---|
Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Thiazoles; Treatment Outcome | 2006 |
Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Rosiglitazone; Thiazoles; Thiazolidinediones; Treatment Outcome | 2006 |
A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Europe; Female; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Thiazoles; Treatment Outcome | 2007 |
A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Bone Density; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Thiazoles; Treatment Outcome; Young Adult | 2011 |
Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
Topics: Alanine Transaminase; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Fatty Liver; Female; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Metformin; Obesity, Abdominal; Thiazoles; Waist-Hip Ratio | 2012 |
Treatment effects on measures of body composition in the TODAY clinical trial.
Topics: Adolescent; Body Composition; Body Mass Index; Child; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Life Style; Male; Metformin; Thiazoles | 2013 |
Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
Topics: Adolescent; Child; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Life Style; Male; Metformin; Thiazoles | 2013 |
Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience.
Topics: Adolescent; Blood Glucose; Child; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Thiazoles | 2013 |
Impact of sex on the heart's metabolic and functional responses to diabetic therapies.
Topics: Analysis of Variance; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diastole; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Echocardiography, Doppler; Eicosapentaenoic Acid; Energy Metabolism; Fatty Acids; Fatty Acids, Omega-3; Female; Health Status Disparities; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Missouri; Myocardium; Positron-Emission Tomography; Recovery of Function; Sex Factors; Stroke Volume; Thiazoles; Time Factors; Treatment Outcome; Triglycerides; Ventricular Function, Left; Ventricular Pressure | 2013 |
Efficacy and safety of avandamet or uptitrated metformin treatment in patients with type 2 diabetes inadequately controlled with metformin alone: a multicenter, randomized, controlled trial.
Topics: Adult; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Thiazoles | 2015 |
METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN.
Topics: Adipose Tissue; Adult; Aging; Body Fat Distribution; Climacteric; Double-Blind Method; Drug Combinations; Female; Humans; Insulin Resistance; Metformin; Middle Aged; Obesity; Overweight; Placebos; Thiazoles; Weight Gain; Weight Loss | 2016 |
Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.
Topics: Adolescent; Anthropometry; Blood Glucose; Body Weight; Child; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypoglycemic Agents; Life Style; Male; Metformin; Risk Factors; Thiazoles; Treatment Outcome | 2017 |
Changes in Visceral and Subcutaneous Fat in Youth With Type 2 Diabetes in the TODAY Study.
Topics: Adiposity; Adolescent; Blood Glucose; Body Fat Distribution; Child; Combined Modality Therapy; Diabetes Mellitus, Type 2; Drug Combinations; Exercise Therapy; Female; Humans; Insulin Resistance; Intra-Abdominal Fat; Life Style; Male; Metformin; Obesity; Sex Factors; Subcutaneous Fat; Thiazoles | 2019 |
Consumption of Beverages Containing Low-Calorie Sweeteners, Diet, and Cardiometabolic Health in Youth With Type 2 Diabetes.
Topics: Adolescent; Beverages; Body Mass Index; Cardiometabolic Risk Factors; Child; Diabetes Mellitus, Type 2; Diet; Diet Records; Dietary Sugars; Drug Combinations; Energy Intake; Female; Humans; Life Style; Longitudinal Studies; Male; Metformin; Rosiglitazone; Surveys and Questionnaires; Sweetening Agents; Thiazoles | 2020 |
15 other study(ies) available for metformin and rosiglitazone-metformin combination
| Article | Year |
|---|---|
Metaglip and Avandamet for type 2 diabetes.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fees, Pharmaceutical; Glipizide; Humans; Hypoglycemic Agents; Metformin; Thiazoles | 2002 |
Dutasteride (Avodart) for benign prostatic hyperplasia.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Azasteroids; Biological Availability; Clinical Trials as Topic; Drug Combinations; Dutasteride; Finasteride; Humans; Male; Metformin; Prostatic Hyperplasia; Thiazoles | 2002 |
New drugs and dosage forms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clobetasol; Dosage Forms; Drug Combinations; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Imidazoles; Metformin; Pharmaceutical Preparations; Phosphodiesterase Inhibitors; Piperazines; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Sulfones; Thiazoles; Triazines; United States; United States Food and Drug Administration; Vardenafil Dihydrochloride | 2003 |
[Blood sugar inspite of maximal metformin dosage. New fixed combination forces HbA1c down].
Topics: Body Mass Index; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Patient Compliance; Placebos; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors | 2003 |
Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Topics: Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypoglycemic Agents; Metformin; Randomized Controlled Trials as Topic; Rosiglitazone; Thiazoles; Thiazolidinediones | 2007 |
Response to Pokharna and Kanna: initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
Topics: Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Drug Combinations; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Thiazoles; Thiazolidinediones | 2008 |
[Avandia and avandamet in the treatment of patients with diabetes mellitus type 2: effects on secretion of some fat tissue hormones].
Topics: Adiponectin; Adipose Tissue; Diabetes Mellitus, Type 2; Drug Combinations; Female; Fibrinolytic Agents; Ghrelin; Humans; Hypoglycemic Agents; Insulin; Leptin; Male; Metformin; Middle Aged; Resistin; Rosiglitazone; Thiazoles; Thiazolidinediones | 2008 |
Rosiglitazone maleate + metformin hydrochloride extend: review of an emerging compound.
Topics: Clinical Trials, Phase III as Topic; Diabetes Mellitus, Type 2; Drug Combinations; Gluconeogenesis; Humans; Hypoglycemic Agents; Metformin; Molecular Structure; Thiazoles; Treatment Outcome | 2009 |
Spectrophotometric and HPLC determinations of anti-diabetic drugs, rosiglitazone maleate and metformin hydrochloride, in pure form and in pharmaceutical preparations.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Hypoglycemic Agents; Metformin; Molecular Structure; Rosiglitazone; Spectrophotometry; Tablets; Thiazoles; Thiazolidinediones | 2009 |
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Mexico; Middle Aged; Pharmacovigilance; Prospective Studies; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2012 |
GSK fights compensation claims from UK patients who took rosiglitazone.
Topics: Compensation and Redress; Drug Combinations; Drug Industry; Humans; Hypoglycemic Agents; Metformin; Rosiglitazone; Safety-Based Drug Withdrawals; Thiazoles; Thiazolidinediones; United Kingdom | 2013 |
Development and validation of spectrophotometric and HPTLC methods for simultaneous determination of rosiglitazone maleate and metformin hydrochloride in the presence of interfering matrix excipients.
Topics: Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Combinations; Excipients; Metformin; Spectrophotometry; Tablets; Thiazoles | 2014 |
Correlated increase of omentin-1 and adiponectin by exenatide, avandamet and dietary change in diet-induced obese rats.
Topics: Adiponectin; Animals; Cytokines; Drug Combinations; Exenatide; Metformin; Obesity; Peptides; Rats; Thiazoles; Venoms | 2013 |
Adiponectin, Insulin Sensitivity, β-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY.
Topics: Adiponectin; Adolescent; Black People; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Drug Combinations; Ethnicity; Female; Glucose Tolerance Test; Health Status Disparities; Hispanic or Latino; Humans; Hypoglycemic Agents; Insulin Resistance; Life Style; Male; Metformin; Thiazoles; Treatment Failure; White People | 2017 |
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study.
Topics: Aged; Dementia; Diabetes Mellitus, Type 2; Drug Combinations; Female; Humans; Hypoglycemic Agents; Longitudinal Studies; Male; Metformin; Pioglitazone; Thiazoles; Thiazolidinediones | 2018 |